Nucleus

About:

Nucleus combines genetic and non-genetic information and calculates the absolute risk scores for people for disease.

Website: https://mynucleus.com/

Top Investors: Founders Fund, Pareto Holdings, Quiet Capital, Edward Lando, SALT Fund

Description:

Nucleus provides genetic analysis of greater breadth, depth, and beauty. Users can upload their genetic information obtained through an established company. The proprietary algorithms will calculate polygenic risk scores and measure disease risk based on analysis of genetic variants and display them in a user-friendly platform.

Total Funding Amount:

$17.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2021-01-01

Founders:

Caio Hachem, Kian Sadeghi

Number of Employees:

1-10

Last Funding Date:

2022-07-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai